eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

GlaxoSmithKline UK
Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 31/03/2011
PIL Altargo 1% Ointment

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 31/03/2011 and displayed until Current
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 10/03/2011 and displayed until 31/03/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 14/10/2010 and displayed until 10/03/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 20/09/2010 and displayed until 14/10/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 22/07/2010 and displayed until 20/09/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 07/04/2010 and displayed until 22/07/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 08/09/2009 and displayed until 07/04/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to MA holder contact details
Updated on 02/05/2008 and displayed until 08/09/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 26/03/2008 and displayed until 02/05/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 24/01/2008 and displayed until 26/03/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  retapamulin